Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
Tango Therapeutics (NASDAQ:TNGX) announced its upcoming participation in the 2025 Cantor Global Healthcare Conference. The company's President and CEO, Barbara Weber, M.D., will participate in a fireside chat on September 3, 2025, from 2:45-3:15 PM ET.
Investors can access the live webcast through the "Events & Presentations" section on the company's investor relations website. The presentation recording will remain available for 90 days following the event.
Tango Therapeutics (NASDAQ:TNGX) ha annunciato la sua partecipazione alla Cantor Global Healthcare Conference 2025. La Presidentessa e CEO dell'azienda, Barbara Weber, M.D., prenderà parte a una fireside chat il 3 settembre 2025, dalle 14:45 alle 15:15 ET.
Gli investitori potranno seguire la diretta streaming dalla sezione "Events & Presentations" del sito investor relations della società. La registrazione della presentazione resterà disponibile per 90 giorni dopo l'evento.
Tango Therapeutics (NASDAQ:TNGX) anunció su participación en la Cantor Global Healthcare Conference 2025. La presidenta y CEO de la compañía, Barbara Weber, M.D., participará en una charla informal el 3 de septiembre de 2025, de 2:45 a 3:15 PM ET.
Los inversores podrán acceder a la transmisión en vivo a través de la sección "Events & Presentations" en la web de relaciones con inversores. La grabación de la presentación estará disponible durante 90 días tras el evento.
Tango Therapeutics (NASDAQ:TNGX)는 2025 Cantor Global Healthcare Conference 참가 소식을 발표했습니다. 회사의 사장 겸 CEO인 Barbara Weber, M.D.가 2025년 9월 3일 동부표준시 기준 오후 2:45~3:15에 파이어사이드 채팅에 참여합니다.
투자자는 회사 투자자관계 웹사이트의 "Events & Presentations" 섹션에서 실시간 웹캐스트에 접속할 수 있습니다. 발표 녹화는 이벤트 종료 후 90일간 제공됩니다.
Tango Therapeutics (NASDAQ:TNGX) a annoncé sa participation à la Cantor Global Healthcare Conference 2025. La présidente et CEO de la société, Barbara Weber, M.D., prendra part à une discussion informelle le 3 septembre 2025, de 14h45 à 15h15 ET.
Les investisseurs pourront accéder à la diffusion en direct via la rubrique "Events & Presentations" du site relations investisseurs de la société. L'enregistrement de la présentation restera disponible pendant 90 jours après l'événement.
Tango Therapeutics (NASDAQ:TNGX) hat seine Teilnahme an der Cantor Global Healthcare Conference 2025 angekündigt. Die Präsidentin und CEO des Unternehmens, Barbara Weber, M.D., wird an einem Fireside-Chat am 3. September 2025, von 14:45 bis 15:15 Uhr ET teilnehmen.
Investoren können den Live-Webcast über den Bereich "Events & Presentations" auf der Investor-Relations-Website des Unternehmens aufrufen. Die Aufzeichnung der Präsentation wird für 90 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Wednesday, September 3 at 2:45-3:15 PM ET.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
